US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

6.400
+0.150+2.40%

Trading Mar 5 11:15 ET

164.98MMarket Cap-5.70P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

58.31%213.91M

--218.65M

--117.91M

165.01%125.19M

--135.13M

-31.54%47.24M

--47.24M

--69M

-Cash and cash equivalents

133.38%40.89M

--77.23M

--16.26M

178.79%15.53M

--17.52M

20.28%5.57M

--5.57M

--4.63M

-Short-term investments

47.12%173.02M

--141.42M

--101.64M

163.17%109.66M

--117.6M

-35.27%41.67M

--41.67M

--64.37M

Other current assets

-48.75%1.23M

--1.67M

--1.8M

118.21%2.52M

--2.4M

48.77%1.15M

--1.15M

--775K

Total current assets

56.43%215.14M

--220.32M

--119.71M

163.90%127.71M

--137.53M

-30.65%48.39M

--48.39M

--69.78M

Non current assets

Net PPE

-34.75%888K

--1.03M

--1.23M

-33.95%1.4M

--1.36M

229.44%2.12M

--2.12M

--642K

-Gross PPE

-68.27%888K

--1.03M

--1.23M

-15.35%2.87M

--2.8M

111.92%3.4M

--3.4M

--1.6M

-Accumulated depreciation

----

-15.39%-1.48M

---1.44M

-33.33%-1.28M

---1.28M

---960K

Other non current assets

-98.06%3K

--3K

--2.62M

894.57%1.28M

--155K

32.99%129K

--129K

--97K

Total non current assets

-41.23%891K

--1.04M

--3.85M

19.43%2.68M

--1.52M

203.65%2.24M

--2.24M

--739K

Total assets

55.37%216.03M

--221.36M

--123.56M

157.50%130.39M

--139.05M

-28.19%50.64M

--50.64M

--70.52M

Liabilities

Current liabilities

Payables

-19.25%1.4M

--734K

--570K

47.67%635K

--1.73M

-34.85%430K

--430K

--660K

-accounts payable

32.54%1.4M

--734K

--570K

47.67%635K

--1.05M

-34.85%430K

--430K

--660K

-Total tax payable

----

--676K

----

Current accrued expenses

-47.49%1.62M

--1.12M

--4.23M

229.92%2.48M

--3.09M

-0.53%752K

--752K

--756K

Current debt and capital lease obligation

-45.50%611K

--484K

--474K

-90.83%464K

--1.12M

304.64%5.06M

--5.06M

--1.25M

-Current debt

----

215.84%3.95M

--3.95M

--1.25M

-Current capital lease obligation

-45.50%611K

--484K

--474K

-58.20%464K

--1.12M

--1.11M

--0

Current deferred liabilities

----

--79K

Current liabilities

-21.92%5.81M

--3.74M

--6.23M

-27.36%5.48M

--7.44M

105.50%7.55M

--7.55M

--3.67M

Non current liabilities

Long term debt and capital lease obligation

--0

--113K

--111K

-86.35%108K

--0

-78.38%791K

--791K

--3.66M

-Long term debt

----

--3.66M

-Long term capital lease obligation

--0

--113K

--111K

-86.35%108K

--0

--791K

--0

Preferred securities outside stock equity

--0

--192.62M

45.39%192.62M

--192.62M

0.00%132.48M

--132.48M

Other non current liabilities

----

--228K

-96.36%110K

--133K

89.42%3.03M

--3.03M

--1.6M

Total non current liabilities

--0

--113K

--192.96M

41.48%192.84M

--192.75M

-1.05%136.3M

--136.3M

--137.74M

Total liabilities

-97.10%5.81M

--3.85M

--199.19M

37.87%198.32M

--200.19M

1.72%143.85M

--143.85M

--141.41M

Shareholders'equity

Share capital

100.00%26K

--26K

--2K

0.00%2K

--13K

-83.33%2K

--2K

--12K

-common stock

100.00%26K

--26K

--2K

0.00%2K

--13K

-83.33%2K

--2K

--12K

-Preferred stock

--0

----

Retained earnings

-52.63%-102.84M

---92.57M

---83.56M

23.22%-75.14M

---67.38M

-32.95%-97.86M

---97.86M

---73.61M

Paid-in capital

4,854.46%312.48M

--310.17M

--7.99M

50.19%7.1M

--6.31M

72.48%4.73M

--4.73M

--2.74M

Gains losses not affecting retained earnings

730.34%561K

---127K

---58K

242.11%108K

---89K

-117.14%-76K

---76K

---35K

Total stockholders'equity

443.82%210.23M

--217.5M

---75.63M

27.12%-67.94M

---61.14M

-31.48%-93.21M

---93.21M

---70.89M

Total equity

443.82%210.23M

--217.5M

---75.63M

27.12%-67.94M

---61.14M

-31.48%-93.21M

---93.21M

---70.89M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	58.31%213.91M	--218.65M	--117.91M	165.01%125.19M	165.01%125.19M	--135.13M	-31.54%47.24M	--47.24M	--69M
-Cash and cash equivalents	133.38%40.89M	--77.23M	--16.26M	178.79%15.53M	178.79%15.53M	--17.52M	20.28%5.57M	--5.57M	--4.63M
-Short-term investments	47.12%173.02M	--141.42M	--101.64M	163.17%109.66M	163.17%109.66M	--117.6M	-35.27%41.67M	--41.67M	--64.37M
Other current assets	-48.75%1.23M	--1.67M	--1.8M	118.21%2.52M	118.21%2.52M	--2.4M	48.77%1.15M	--1.15M	--775K
Total current assets	56.43%215.14M	--220.32M	--119.71M	163.90%127.71M	163.90%127.71M	--137.53M	-30.65%48.39M	--48.39M	--69.78M
Non current assets
Net PPE	-34.75%888K	--1.03M	--1.23M	-33.95%1.4M	-33.95%1.4M	--1.36M	229.44%2.12M	--2.12M	--642K
-Gross PPE	-68.27%888K	--1.03M	--1.23M	-15.35%2.87M	-15.35%2.87M	--2.8M	111.92%3.4M	--3.4M	--1.6M
-Accumulated depreciation	----	----	----	-15.39%-1.48M	-15.39%-1.48M	---1.44M	-33.33%-1.28M	---1.28M	---960K
Other non current assets	-98.06%3K	--3K	--2.62M	894.57%1.28M	894.57%1.28M	--155K	32.99%129K	--129K	--97K
Total non current assets	-41.23%891K	--1.04M	--3.85M	19.43%2.68M	19.43%2.68M	--1.52M	203.65%2.24M	--2.24M	--739K
Total assets	55.37%216.03M	--221.36M	--123.56M	157.50%130.39M	157.50%130.39M	--139.05M	-28.19%50.64M	--50.64M	--70.52M
Liabilities
Current liabilities
Payables	-19.25%1.4M	--734K	--570K	47.67%635K	47.67%635K	--1.73M	-34.85%430K	--430K	--660K
-accounts payable	32.54%1.4M	--734K	--570K	47.67%635K	47.67%635K	--1.05M	-34.85%430K	--430K	--660K
-Total tax payable	----	----	----	----	----	--676K	----	----	----
Current accrued expenses	-47.49%1.62M	--1.12M	--4.23M	229.92%2.48M	229.92%2.48M	--3.09M	-0.53%752K	--752K	--756K
Current debt and capital lease obligation	-45.50%611K	--484K	--474K	-90.83%464K	-90.83%464K	--1.12M	304.64%5.06M	--5.06M	--1.25M
-Current debt	----	----	----	----	----	----	215.84%3.95M	--3.95M	--1.25M
-Current capital lease obligation	-45.50%611K	--484K	--474K	-58.20%464K	-58.20%464K	--1.12M	--1.11M	--1.11M	--0
Current deferred liabilities	----	----	----	----	----	----	----	----	--79K
Current liabilities	-21.92%5.81M	--3.74M	--6.23M	-27.36%5.48M	-27.36%5.48M	--7.44M	105.50%7.55M	--7.55M	--3.67M
Non current liabilities
Long term debt and capital lease obligation	--0	--113K	--111K	-86.35%108K	-86.35%108K	--0	-78.38%791K	--791K	--3.66M
-Long term debt	----	----	----	----	----	----	----	----	--3.66M
-Long term capital lease obligation	--0	--113K	--111K	-86.35%108K	-86.35%108K	--0	--791K	--791K	--0
Preferred securities outside stock equity	--0	--0	--192.62M	45.39%192.62M	45.39%192.62M	--192.62M	0.00%132.48M	--132.48M	--132.48M
Other non current liabilities	----	----	--228K	-96.36%110K	-96.36%110K	--133K	89.42%3.03M	--3.03M	--1.6M
Total non current liabilities	--0	--113K	--192.96M	41.48%192.84M	41.48%192.84M	--192.75M	-1.05%136.3M	--136.3M	--137.74M
Total liabilities	-97.10%5.81M	--3.85M	--199.19M	37.87%198.32M	37.87%198.32M	--200.19M	1.72%143.85M	--143.85M	--141.41M
Shareholders'equity
Share capital	100.00%26K	--26K	--2K	0.00%2K	0.00%2K	--13K	-83.33%2K	--2K	--12K
-common stock	100.00%26K	--26K	--2K	0.00%2K	0.00%2K	--13K	-83.33%2K	--2K	--12K
-Preferred stock	--0	--0	----	----	----	----	----	----	----
Retained earnings	-52.63%-102.84M	---92.57M	---83.56M	23.22%-75.14M	23.22%-75.14M	---67.38M	-32.95%-97.86M	---97.86M	---73.61M
Paid-in capital	4,854.46%312.48M	--310.17M	--7.99M	50.19%7.1M	50.19%7.1M	--6.31M	72.48%4.73M	--4.73M	--2.74M
Gains losses not affecting retained earnings	730.34%561K	---127K	---58K	242.11%108K	242.11%108K	---89K	-117.14%-76K	---76K	---35K
Total stockholders'equity	443.82%210.23M	--217.5M	---75.63M	27.12%-67.94M	27.12%-67.94M	---61.14M	-31.48%-93.21M	---93.21M	---70.89M
Total equity	443.82%210.23M	--217.5M	---75.63M	27.12%-67.94M	27.12%-67.94M	---61.14M	-31.48%-93.21M	---93.21M	---70.89M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

CTNM Contineum Therapeutics

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trending Stocks